Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 861177 NEW YORK, NY
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,058,737
+$676,359 QoQ
Shares Held
105,739
+42.6% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 172 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 33% Shared 0% None 67%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. MLTX ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in MLTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,058,737 105,739
2026-03-31 $1,382,378 74,162
2025-06-30 $904,540 19,164
2025-03-31 $1,711,420 43,804
2024-12-31 $2,287,078 42,236
2024-09-30 $1,805,741 35,814
2024-06-30 $801,748 18,234
2024-03-31 $765,052 15,231
2023-12-31 $919,799 15,231
2023-09-30 $865,146 15,178